JOHN G ULLMAN & ASSOCIATES INC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
JOHN G ULLMAN & ASSOCIATES INC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$18,608,803
-0.3%
182,690
-1.2%
3.04%
+5.7%
Q2 2023$18,661,791
+107771.6%
184,935
-1.7%
2.88%
+7.0%
Q1 2023$17,300
-1.8%
188,045
-3.2%
2.69%
-4.2%
Q4 2022$17,619
-99.9%
194,211
-1.9%
2.81%
+6.7%
Q3 2022$15,042,000
-5.7%
197,894
+4.9%
2.63%
+2.8%
Q2 2022$15,952,000
-2.5%
188,714
+1.2%
2.56%
+12.9%
Q1 2022$16,358,000
+4.9%
186,419
+4.6%
2.27%
+5.7%
Q4 2021$15,591,000
+9.0%
178,239
+1.9%
2.14%
+10.2%
Q3 2021$14,308,000
-10.5%
174,954
-0.1%
1.95%
-6.5%
Q2 2021$15,979,000
+5.3%
175,134
-1.3%
2.08%
+2.3%
Q1 2021$15,170,000
-5.7%
177,464
+4.1%
2.04%
-18.4%
Q4 2020$16,094,000
+22.2%
170,433
+12.5%
2.50%
-8.5%
Q3 2020$13,173,000
-1.1%
151,485
-0.7%
2.73%
-16.1%
Q2 2020$13,318,000
+5.7%
152,485
-0.2%
3.25%
-2.8%
Q1 2020$12,601,000
-14.3%
152,835
-1.6%
3.34%
+32.0%
Q4 2019$14,710,000
+7.1%
155,350
-1.8%
2.53%
+1.4%
Q3 2019$13,741,000
-5.2%
158,125
-0.4%
2.50%
-2.1%
Q2 2019$14,500,000
-5.4%
158,800
-0.4%
2.55%
-8.1%
Q1 2019$15,322,000
+10.3%
159,375
-1.5%
2.77%
-1.0%
Q4 2018$13,886,000
-0.8%
161,825
-0.4%
2.80%
+10.0%
Q3 2018$14,002,000
+13.9%
162,508
-0.1%
2.55%
+9.5%
Q2 2018$12,292,000
-5.0%
162,718
+1.7%
2.32%
-7.1%
Q1 2018$12,939,000
-2.7%
160,043
+1.1%
2.50%
-5.7%
Q4 2017$13,297,000
-2.0%
158,368
+0.2%
2.65%
+0.2%
Q3 2017$13,574,000
+38.5%
158,110
+34.7%
2.65%
+36.2%
Q2 2017$9,799,000
+16.2%
117,390
+3.4%
1.94%
+11.5%
Q1 2017$8,432,000
+10.3%
113,525
+8.2%
1.74%
+8.8%
Q4 2016$7,646,000
+80.4%
104,964
+95.5%
1.60%
+83.7%
Q3 2016$4,239,000
+6.9%
53,684
+11.7%
0.87%
+7.1%
Q2 2016$3,965,000
+12.6%
48,049
-1.1%
0.81%
-1.5%
Q1 2016$3,521,000
-19.6%
48,599
-4.5%
0.83%
-14.7%
Q4 2015$4,380,000
-9.0%
50,908
-2.8%
0.97%
-15.2%
Q3 2015$4,814,000
-13.3%
52,374
-7.2%
1.14%
+9.3%
Q2 2015$5,552,000
-6.9%
56,454
-6.7%
1.04%
-7.8%
Q1 2015$5,965,000
+4.3%
60,489
-2.0%
1.13%
+5.3%
Q4 2014$5,718,000
-3.7%
61,709
-2.1%
1.08%
-5.7%
Q3 2014$5,936,000
-18.3%
63,059
-21.4%
1.14%
-13.9%
Q2 2014$7,264,000
+4.5%
80,239
-1.8%
1.33%
+3.1%
Q1 2014$6,949,000
+0.8%
81,739
-4.7%
1.29%
-2.3%
Q4 2013$6,897,000
+1.4%
85,799
-3.2%
1.32%
-4.9%
Q3 2013$6,800,000
-4.6%
88,649
-12.0%
1.38%
-6.9%
Q2 2013$7,127,000100,7901.49%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
Newman Dignan & Sheerar, Inc. 3,739$353,074,00056.77%
Susquehanna International Securities, Ltd. 118,837$11,222,0008.15%
MANAGED ASSET PORTFOLIOS, LLC 336,762$31,800,0005.59%
Martin Investment Management, LLC 169,019$15,960,0005.10%
SCHARF INVESTMENTS, LLC 1,197,539$113,083,0004.26%
GARLAND CAPITAL MANAGEMENT INC 50,705$4,788,0004.06%
Mawer Investment Management Ltd. 6,625,594$625,655,0003.69%
SPHERA FUNDS MANAGEMENT LTD. 429,000$40,510,0003.60%
First Fiduciary Investment Counsel, Inc. 196,693$18,574,0003.48%
PROFESSIONAL ADVISORY SERVICES INC 227,971$21,527,0003.46%
View complete list of NOVARTIS A G shareholders